Cargando…

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy

IgA nephropathy (IgAN) remains one of the most common forms of glomerulonephritis, especially in developed countries with a low prevalence of infectious diseases. Despite supportive measures that slow the rate of progression of chronic kidney disease (CKD) in IgAN, many patients still progress to en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aameish, Muhammad, Jovanovic, Milica, John, Mala A, Baumstein, Donald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664351/ https://www.ncbi.nlm.nih.gov/pubmed/34912597 http://dx.doi.org/10.7759/cureus.19446

Ejemplares similares

A Rare Presentation of IgA Nephropathy in a 62-Year-Old Hispanic Female
por: Kurkowski, Sarah C, et al.
Publicado: (2023)

Prolonged Altered Mental Status in a Diabetic Hemodialysis Patient
por: Jalalzadeh, Mojgan, et al.
Publicado: (2021)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Association between VDR gene FokI polymorphism and renal function in patients with IgA nephropathy
por: Mo, Man-Qiu, et al.
Publicado: (2019)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Gitelman Syndrome Provisionally Diagnosed During the First Presentation of Diabetic Ketoacidosis
por: Jalalzadeh, Mojgan, et al.
Publicado: (2021)

The Vicious Cycle of Hypothyroidism and Severe Proteinuria: A Case Report
por: Li, Shuojohn, et al.
Publicado: (2022)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

Administration of Once-daily Canagliflozin to a Non-diabetic Patient in Addition to Standard Aerobic Exercise: A Case Report
por: Roy, Sayak
Publicado: (2019)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy
por: Bagchi, Soumita, et al.
Publicado: (2022)

Elevated Adrenocorticotropic Hormone, Hypercortisolism, and Marked Hypernatremia
por: Wassel, Elias, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Renal Effects of High-Dose Versus Low-Dose Lisinopril in Patients With Diabetic Nephropathy
por: Rashid, Farah R, et al.
Publicado: (2022)

Association Between Monocyte-to-High-Density Lipoprotein (HDL) Cholesterol Ratio and Proteinuria in Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study
por: D, Yashilha, et al.
Publicado: (2023)

Role of Magnesium in Diabetic Nephropathy for Better Outcomes
por: Mamilla, Mahesh, et al.
Publicado: (2023)

Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2013)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy
por: Lee, Ji-Hye, et al.
Publicado: (2020)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Effect of Non-Surgical Periodontal Therapy on Systemic Inflammatory Markers, Glycemic Status and Levels of Proteinuria in Type 2 Diabetic and Non-Diabetic Patients With Chronic Periodontitis
por: Sundaram, S Gopalakrishnan, et al.
Publicado: (2023)

Evaluation of Neutrophil/Lymphocyte Ratio, Low-Density Lipoprotein/Albumin Ratio, and Red Cell Distribution Width/Albumin Ratio in the Estimation of Proteinuria in Uncontrolled Diabetic Patients
por: Tutan, Duygu, et al.
Publicado: (2023)

A Narrative Review of New Treatment Options for Diabetic Nephropathy
por: Pillai, Aadhira, et al.
Publicado: (2023)

A novel clinical−radiomic nomogram for the crescent status in IgA nephropathy
por: Qin, Xiachuan, et al.
Publicado: (2023)

Utility of Urinary Nephrin in Patients With and Without Diabetic Nephropathy and Its Correlation With Albuminuria
por: Surya, Manupati, et al.
Publicado: (2021)

Adiponectin Can Be an Early Predictable Marker for Type 2 Diabetes Mellitus and Nephropathy
por: Ganesh, Veluri, et al.
Publicado: (2022)

Comment on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Nasri, H.
Publicado: (2014)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Concurrent Presentation of Diabetic Nephropathy and Type 1 Diabetes Mellitus in a Pediatric Patient
por: Manazir, Sana, et al.
Publicado: (2021)

Endothelin Receptor Antagonists as a Potential Treatment of Diabetic Nephropathy: A Systematic Review
por: Ahmad, Noorain, et al.
Publicado: (2021)

A Cost-Variation Analysis of Drugs Available in the Indian Market for the Management of Diabetic Nephropathy
por: Advani, Manjari, et al.
Publicado: (2022)

Association of obesity with the development of end stage renal disease in IgA nephropathy patients
por: Wang, Siqing, et al.
Publicado: (2023)

Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
por: Sonkar, Satyendra K, et al.
Publicado: (2023)

A Study to Evaluate the Association Between Thyroid Function and Serum Potassium Level in Diagnosed Cases of Diabetic Nephropathy
por: Boruah, Polina, et al.
Publicado: (2021)

Multifocal C-cell Hyperplasia and Marked Hypercalcitoninemia in a Diabetic Patient Treated With Glucagon-Like Peptide-1 Agonist With Concurrent Multinodular Goiter and Hyperparathyroidism
por: Zou, Sifan, et al.
Publicado: (2023)

Systematic Review to Gauge the Effect of Levothyroxine Substitution on Progression of Diabetic Nephropathy in Patients With Hypothyroidism and Type 2 Diabetes Mellitus
por: Manshahia, Prabhleen Kaur, et al.
Publicado: (2023)

Underutilization of Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Nephropathy Patients in Government-Run Hospitals in India
por: Maradia, Jay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kj24jt1tnpqttgtcb3blbuku6a